The PODD event features a wide range of innovative drug delivery technologies that could potentially improve the delivery of various types of drugs, including proteins, peptides, oligonucleotides, biologics, and small molecules.
Key topics for PODD 2019 Include:
Nanotechnology for Immuno-oncology applications
Formulation and device life cycle management for biotherapeutics
Translating gene therapies into medicine
Future trends and technologies for biologics and IV pharmaceuticals
Device platform technologies and strategies
Connected health drug delivery products
Biologically-derived drug delivery systems
Technical considerations for development of patient-centered therapies
Delivering new therapeutic modalities
Reasons to Attend:
Hear from renowned biomedical engineer and entrepreneur, Dr Robert Langer of MIT, as well as other leading key opinion leaders from industry and academia
Learn about the latest drug delivery technology solutions for both small and large molecule drugs, ranging from oral, transdermal, and transmucosal dosage forms to more patient-friendly delivery devices (more than 45 presentations and 50 exhibitors).
Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and exploring areas for potential collaboration (more than 8 hours of networking).
Discover the current drug delivery needs of pharma and biotech companies and determining what they are looking for in terms of external delivery technologies.
Participate in discussions with colleagues tackling the latest delivery challenges in areas such as gene therapy and biologics-based new therapeutic modalities
Standard Rate: USD 2195.0,
Academic/Non-Profit/Government: USD 1097.5
Speakers: Sangeeta Bhatia, MD, PhD, Jeffrey Karp, PhD, Robert Langer, PhD, Allen Templeton, PhD, Giovanni Traverso, PhD, Katherine High, Beate Bittner, PhD, Advait Badkar, PhD, Tommaso Borghi, PhD, Rebecca Carrier, PhD, Christopher Coletta, PhD, Michael Cucolo, Brian Davideit, Shawn Davis, PhD, Kevin Deane, Diane Doughty, PhD, Stephen Fournier, MBA, Sudhakar Garad, PhD, Simon Geißler, PhD, Marian Gindy, PhD, Keith Horspool, PhD, Kristian Kolind, PhD, Christopher Kovalchick, PhD, André LaFreniere, Lidia Massimi, John Merhige, Sudeshna Dutta Ray, Mathias Romacker, Ronak Savla, PhD, PharmD, Johannes Schmidt, PhD, Kurt R Sedo, Rishab Shyam, PhD, Lilly Stairs, Cornell Stamoran, PhD, Molly Story, PhD, Anand Subramony, PhD, Renee Tannenbaum, PharmD, Ian Thompson, Paul Upham, Rémy Vomscheid, PhD, Katarina Vulic, PhD, Ulrich Bruggemann, , Ann L Daugherty, PhD, Manuel Sanchez-Felix, PhD, Srini Sridharan, PhD, Dhairya Mehta, Patrick Lim Soo, PhD, Samir Mitragotri, PhD